In recent years, Pfizer, Bristol Myers Squibb, and Medical Properties Trust have faced challenges but are making progress. High dividend yields can be sustainable, as seen with these three stocks yielding above 4%. Pfizer is expanding its pipeline and cutting costs. Bristol Myers Squibb has new medicines contributing to sales and label expansions. Medical Properties Trust overcame financial challenges and diversified its tenant base. These companies are solid choices for income-seeking investors. Pfizer, with a 6.7% forward yield, is turning the tide with new medicines and cost-cutting measures. Bristol Myers Squibb, offering a 4.6% forward yield, is launching newer products and maintaining exclusivity. Medical Properties Trust, with a 7.1% forward yield, has diversified its tenant base and improved its financial outlook.

Read more at Nasdaq: 3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This Year